Intramucosal ganglion cells are common in diverticular disease

Department of Pathology, University Health Network/Toronto Medical Laboratories, University of Toronto, Toronto, Canada.
Pathology (Impact Factor: 2.19). 09/2008; 40(5):470-4. DOI: 10.1080/00313020802198028
Source: PubMed


Ganglion cells were thought not to occur within the mucosa of the normal colon and found only in the setting of inflammatory bowel disease and neuronal intestinal dysplasia. The aim of this study was to firmly establish the incidence of intramucosal ganglion cells in diverticular disease, normal mucosa and in a spectrum of gastrointestinal diseases.
We retrospectively reviewed 50 resection specimens from cases of symptomatic diverticular disease and biopsies and/or resection specimens for several neoplastic and non-neoplastic gastrointestinal diseases (50 normal and 120 cases for a variety of gastrointestinal diseases). Normal cases were constituted by biopsies with no clinical history of large bowel disease and no pathology detected microscopically.
All 50 cases of diverticular disease contained intramucosal ganglion cells, located within the muscularis mucosae (49/50 cases) as well as within the lamina propria in nine cases. Intramucosal ganglion cells occurred throughout the colorectum within the muscularis mucosae or lamina propria in normal mucosa in 11 cases and in a further 26 colorectal specimens with Crohn's disease (11/20), ulcerative colitis (11/20), adenocarcinoma (1/20), tubular adenoma (2/20), and mucosal prolapse (1/20). None of the 20 hyperplastic polyps contained intramucosal ganglion cells.
We have firmly established the existence of the intramucosal ganglion cells in normal and diseased colorectum, especially in the mucosa of cases of diverticular disease (100% of cases), Crohn's disease and ulcerative colitis. These three conditions are linked by motility abnormalities which may underlie the reason for the presence of intramucosal ganglion cells.

5 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a 180 nm CMOS technology with dual gate oxide (DGO) optimized for low power and low cost consumer wireless products. To minimize cost and maximize manufacturability, super halo is used for the first time to integrate 70 Å 2.5-3.3 V I/O devices with either 130 nm/29 Å or 150 nm/35 Å low leakage (LL) pÅ/μm devices, eliminating three normally-required masks. Core LL devices optimized for 1.5 V and 1.8 V are available to maximize circuit design compatibility and IP reuse. Both LL devices yield superior performance, and less I<sub>on</sub>/I<sub>off</sub> sensitivity vs. gate-length control for robust manufacturing as compared to recently reported LL devices. This technology also features an all-layer copper/low-k interlayer dielectric backend for speed improvement and dynamic power reduction
    VLSI Technology, 2000. Digest of Technical Papers. 2000 Symposium on; 02/2000
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Disorders of colonic motor and sensory function are common among children and adults and pose significant diagnostic and therapeutic challenges; the purpose of this review, therefore, was to critically assess the recent literature on this topic. Considerable progress has been made at the ultrastructural, molecular and electrophysiological level in understanding the normal functions of the muscles, nerves and interstitial cells that generate and control colonic motility. Furthermore, abnormalities in these cell types and in the interstitial cells of Cajal, in particular, have been identified in a number of disease states. Testing of colonic motor and sensory function in clinical practice continues to be a challenge due, in part, not only to the technical issues presented by accessing the organ but also to the intrinsic variability of its physiology. These have not been auspicious times for advances in the therapy of disturbed colonic motility; new agents or new applications for 'old' agents continue to be explored as are more innovative approaches such as those based on neural stimulation and cell therapy. Considerable progress has been made in understanding the basic pathophysiology of colonic dysmotility; clinical diagnostics and therapeutics continue to lag behind.
    Current opinion in gastroenterology 09/2009; 26(1):53-60. DOI:10.1097/MOG.0b013e328332c977 · 4.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although diverticular disease of the colon (diverticulosis) is a frequent finding in Western countries, its pathophysiologic grounds are still only partially understood. Traditionally considered as an age-related condition, colonic diverticulosis is probably the final result of several factors concurring together to determine the anatomo-functional abnormalities eventually causing outpouching of the viscus' mucosa. Among these factors, a relevant role seems to be played by an abnormal neuromuscular function of the large bowel, as shown by abnormal myoelectrical and motor function repeatedly described in these patients, as well as by altered visceral perception. These anomalies might be related to the recent demonstration of derangement of enteric innervation (especially involving interstitial cells of Cajal and enteric glial cells), mucosal neuropeptides, and mucosal inflammation. The latter may have a role of paramount importance in the development of visceral hypersensitivity, responsible for abdominal pain in a subset of patients.
    Digestive Diseases 05/2012; 30(1):24-8. DOI:10.1159/000335702 · 2.18 Impact Factor
Show more